Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Cancer Res. 2009 Sep 22;69(19):7721–7728. doi: 10.1158/0008-5472.CAN-09-1419

Figure 2.

Figure 2

Metabolite profile in mouse tissues after intravenous injection of parent radiotracers, FCH and D4-FCH, assessed by radio-HPLC. The % radioactivity remaining at 30 min in the form of parent radiotracer, phosphocholine or betaine analogs, as well as that of unknown metabolites are shown for (a) liver, (b) kidney and (c) HCT116 tumor. In the case of tumor, additional comparisons were done with [11C]choline.